MUFG Americas’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10
Closed 898
2022
Q3
$0 Buy
+10
New +$646 ﹤0.01% 944
2018
Q1
Sell
-583
Closed -$25K 1033
2017
Q4
$25K Sell
583
-80
-12% -$3.74K ﹤0.01% 702
2017
Q3
$35K Buy
663
+340
+105% +$19K ﹤0.01% 631
2017
Q2
$19K Hold
323
﹤0.01% 729
2017
Q1
$15K Buy
323
+58
+22% +$2.89K ﹤0.01% 776
2016
Q4
$14K Buy
265
+30
+13% +$1.45K ﹤0.01% 783
2016
Q3
$10K Hold
235
﹤0.01% 854
2016
Q2
$9K Buy
235
+140
+147% +$6.15K ﹤0.01% 883
2016
Q1
$4K Buy
+95
New +$3.92K ﹤0.01% 1006
2015
Q4
Sell
-86
Closed -$3K 1228
2015
Q3
$3K Buy
86
+25
+41% +$1.09K ﹤0.01% 1066
2015
Q2
$2K Buy
+61
New +$2.1K ﹤0.01% 1104

Other funds holding SYNH

MUFG Americas's SYNH Position: Q4 2022 in Review

MUFG Americas sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 10 shares.

MUFG Americas first reported a position in SYNH in Q2 2015 and held it in 11 quarters. The position peaked at $35K in Q3 2017. 305 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • MUFG Americas reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • MUFG Americas sold 10 Syneos Health, Inc. Class A Common Stock shares in Q4 2022.
  • MUFG Americas first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 11 quarters.
  • MUFG Americas's Syneos Health, Inc. Class A Common Stock position peaked at $35K in Q3 2017.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on MUFG Americas's 13F filing for Q4 2022.